Show simple item record

dc.creatorMoschonas G.D., Tsakogiannis D., Lamprou K.A., Mastora E., Dimitriou T.G., Kyriakopoulou Z., Kottaridi C., Karakitsos P., Markoulatos P.en
dc.date.accessioned2023-01-31T09:01:26Z
dc.date.available2023-01-31T09:01:26Z
dc.date.issued2017
dc.identifier10.1099/jmm.0.000563
dc.identifier.issn00222615
dc.identifier.urihttp://hdl.handle.net/11615/76757
dc.description.abstractPurpose. Polymorphic variability in the tumour-suppressor protein p53 at codon 72 has a considerable impact on cervical cancer development. The present study clarified the association between p53 codon 72 genotypes and the risk of cervical disease in Greek patients. We also examined whether the presence of specific p53 genotypes in combination with HPV16 variants or E6 T350G sequence variation can modify an individual’s susceptibility to cervical disease. Methodology. The analysis of p53 genotypes was performed through PCR-RFLP. Sequence and phylogenetic tree analyses of the HPV16 E6 gene were also performed in order to identify HPV16 variants and T350G sequence variation. Results/Key findings. The outcomes of the present analysis revealed that women who are homozygous for the arg genotype are at a 4.17-fold higher risk of developing HPV16-associated HSIL+ (OR=4.17, 95%CI:1.48-4.9, P=0.0049). Moreover, p53 arg/arg patients infected by an HPV16 prototype strain were associated with an increased risk of more severe lesions, while a significant relationship between the p53 arg/arg genotype in patients with T350G sequence variation and the risk of highgrade squamous intraepithelial lesions (HSILs) was revealed. Conclusion. The oncogenic potential of the virus is increased by the presence of the p53 arg/arg genotype in the Greek population in such a way that the specific protein interaction E6 (L83V)-p53 (Arg-72) can modify an individual’s susceptibility to cervical disease. © 2017 The Authors.en
dc.language.isoenen
dc.sourceJournal of Medical Microbiologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85029575302&doi=10.1099%2fjmm.0.000563&partnerID=40&md5=1afcc60be24d7f2aa061f583909419a0
dc.subjectarginineen
dc.subjectprotein p53en
dc.subjectAfricanen
dc.subjectArticleen
dc.subjectAsian Americanen
dc.subjectclinical articleen
dc.subjectcodonen
dc.subjectcontrolled studyen
dc.subjectdisease severityen
dc.subjectEuropeanen
dc.subjectfemaleen
dc.subjectgenetic polymorphismen
dc.subjectgenotypeen
dc.subjectGreeceen
dc.subjecthumanen
dc.subjectHuman papillomavirus type 16en
dc.subjecthuman tissueen
dc.subjectinfection risken
dc.subjectmaximum likelihood methoden
dc.subjectnonhumanen
dc.subjectpapillomavirus infectionen
dc.subjectphylogenetic treeen
dc.subjectpolymerase chain reactionen
dc.subjectpriority journalen
dc.subjectprospective studyen
dc.subjectrestriction fragment length polymorphismen
dc.subjectsequence analysisen
dc.subjectuterine cervix dysplasiaen
dc.subjectvirus strainen
dc.subjectMicrobiology Societyen
dc.titleAssociation of codon 72 polymorphism of p53 with the severity of cervical dysplasia, E6-T350G and HPV16 variant lineages in HPV16-infected womenen
dc.typejournalArticleen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record